Clinica Universidad de Navarra (Cun)

Pamplona 31008

3 studies enrolling now · 14 studies all time

What they study most

Adult-type Diffuse Gliomas, Advanced Malignancies, Astrocytoma, Grade III, Bladder Cancer, Castration Resistant Prostate Cancer, Chronic Graft-versus-host Disease, Colorectal Cancer, Gastric/ Gastroesophageal Junction, Glioblastoma, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Hepatocellular Carcinoma, Lymphoma

Studies at this site

• Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies — Recruiting now
• A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma — Recruiting now
• Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma — Recruiting now
• Rostock International Parkinson's Disease Study (ROPAD) — Completed
• Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations — Stopped early
• Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207) — Stopped early
• INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma — Stopped early
• GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Stopped early
• A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma — Stopped early
• Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1) — Completed
• A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202) — Completed
• Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo — Completed
• Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies — Completed
• INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors — Completed